Ladja, Sitti Mira .

HRN: 18-94-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2023
CEFUROXIME 750MG (VIAL)
10/07/2023
10/13/2023
IVT
350mg
Q8hrs
Uti
Waiting Final Action 
10/09/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
10/09/2023
10/15/2023
IV
60mg
OD
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: